Monash IVF Group Limited (MVF.AX)

AUD 1.22

(-1.21%)

EBITDA Summary of Monash IVF Group Limited

Monash IVF Group Limited's latest annual EBITDA in 2024 was 13.02 Million AUD , down -73.14% from previous year.
Monash IVF Group Limited's latest quarterly EBITDA in 2024 FY was N/A , up 19.66% from previous quarter.
Monash IVF Group Limited reported an annual EBITDA of 48.48 Million AUD in 2023, up 10.26% from previous year.
Monash IVF Group Limited reported an annual EBITDA of 45.69 Million AUD in 2022, down -4.15% from previous year.
Monash IVF Group Limited reported a quarterly EBITDA of N/A for 2024 FY, up 19.66% from previous quarter.
Monash IVF Group Limited reported a quarterly EBITDA of 29.96 Million AUD for 2024 Q2, up 23.99% from previous quarter.

Annual EBITDA Chart of Monash IVF Group Limited (2024 - 2013)

Historical Annual EBITDA of Monash IVF Group Limited (2024 - 2013)

Year	EBITDA	EBITDA Growth
2024	13.02 Million AUD	-73.14%
2023	48.48 Million AUD	10.26%
2022	45.69 Million AUD	-4.15%
2021	51.2 Million AUD	70.67%
2020	32.84 Million AUD	-23.37%
2019	36.45 Million AUD	-1.6%
2018	38.11 Million AUD	-23.19%
2017	48.98 Million AUD	-1.74%
2016	49.61 Million AUD	19.83%
2015	40.96 Million AUD	6.8%
2014	38.35 Million AUD	12.55%
2013	34.07 Million AUD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q4	-27.87 Million AUD	-193.03%
2024 FY	- AUD	19.66%
2024 Q2	29.96 Million AUD	23.99%
2023 Q4	25.61 Million AUD	3.46%
2023 Q2	24.76 Million AUD	30.82%
2023 FY	- AUD	10.26%
2022 Q2	26.76 Million AUD	16.22%
2022 Q4	18.92 Million AUD	-29.28%
2022 FY	- AUD	-4.15%
2021 FY	- AUD	70.67%
2021 Q2	24.71 Million AUD	69.12%
2021 Q4	23.03 Million AUD	-6.82%
2020 Q4	14.61 Million AUD	-19.77%
2020 FY	- AUD	-23.37%
2020 Q2	18.21 Million AUD	-1.49%
2019 Q2	19.32 Million AUD	18.82%
2019 FY	- AUD	-1.6%
2019 Q4	18.49 Million AUD	-4.29%
2018 Q4	16.26 Million AUD	-21.76%
2018 FY	- AUD	-23.19%
2018 Q2	20.78 Million AUD	-9.52%
2017 Q2	25.26 Million AUD	2.77%
2017 FY	- AUD	-1.74%
2017 Q4	22.97 Million AUD	-9.07%
2016 FY	- AUD	19.83%
2016 Q4	24.58 Million AUD	0.31%
2016 Q2	24.5 Million AUD	13.26%
2015 Q4	21.63 Million AUD	11.93%
2015 FY	- AUD	6.8%
2015 Q2	19.32 Million AUD	-0.22%
2014 Q2	18.98 Million AUD	32.04%
2014 FY	- AUD	12.55%
2014 Q4	19.37 Million AUD	2.05%
2013 Q4	14.37 Million AUD	-27.02%
2013 FY	- AUD	0.0%
2013 Q2	19.69 Million AUD	0.0%

Peer EBITDA Comparison of Monash IVF Group Limited

Name	EBITDA	EBITDA Difference
Australian Clinical Labs Limited	181.83 Million AUD	92.837%
BCAL Diagnostics Limited	-5.66 Million AUD	329.847%
Genetic Signatures Limited	-20.33 Million AUD	164.043%
Genetic Technologies Limited	-11.43 Million AUD	213.947%
Healius Limited	-298.09 Million AUD	104.369%
Imagion Biosystems Limited	-13.69 Million AUD	195.095%
Integral Diagnostics Limited	12.33 Million AUD	-5.602%
INOVIQ Ltd	-6.63 Million AUD	296.355%
Microba Life Sciences Limited	-22.8 Million AUD	157.105%
Rhythm Biosciences Limited	-6.79 Million AUD	291.66%
Sonic Healthcare Limited	1.65 Billion AUD	99.215%